US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALPS Medical Breakthroughs ETF

70.33

+1.692.46%

Post-market: 70.330.00000.00%19:30 EDT

Volume:86.82K

Turnover:6.09M

Market Cap:240.88M

PE:- -

High:70.59

Open:69.39

Low:69.39

Close:68.64

52wk High:70.85

52wk Low:34.50

Shares:3.43M

Float Shares:3.43M

Volume Ratio:1.77

T/O Rate:2.53%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sabio Boosts Margins and Programmatic Growth Ahead of Election-Driven Second Half

Should Xenon’s Wider Q2 Losses to Fund Neurology Pipeline Require Action From Xenon (XENE) Investors?

Simply Wall St.

Sabio Secures US$1.5 Million High-Interest Term Loan to Support Working Capital

AbbVie Closes USD 10B Multi-Tranche Senior Notes Offering to Fund Apogee Deal

CG Oncology Director Leonard Post Disposes of USD 74,540 in Common Shares

China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks

Xenon Pharmaceuticals Director Steven Gannon Disposes of 10,000 Common Shares for $640,550

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)

Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure

Apogee Therapeutics, Inc. : Btig Cuts to Neutral from Buy

THOMSON REUTERS

Apogee Therapeutics Gelar Rapat Khusus Pemegang Saham Lewat Webcast Langsung

Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)

Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development

J.P. Morgan Remains a Buy on Xenon (XENE)

AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit

Apogee Therapeutics’ Merger Faces Significant Execution Risks, Potential $381 Million Termination Fee and Stock Price Pressure

Apogee Net Loss Widens to $85.85 Million in Q2 FY26; R&D Expenses Rise to $67.3 Million

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

THOMSON REUTERS

Apogee Therapeutics, - Q2 2026 Net Loss $85.90 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/SBIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","market":"US","secType":"STK","nameCN":"ALPS Medical Breakthroughs ETF","latestPrice":70.33,"timestamp":1787688000000,"preClose":68.64,"halted":0,"volume":86817,"hourTrading":{"tag":"盘后","latestPrice":70.33,"preClose":70.33,"latestTime":"19:30 EDT","volume":91,"amount":6415.95,"timestamp":1787700600971,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02462121212121209,"floatShares":3425000,"shares":3425000,"eps":0,"marketStatus":"Not Yet Opened","change":1.69,"latestTime":"08-25 16:00:00 EDT","open":69.39,"high":70.59,"low":69.39,"amount":6093466.45116,"amplitude":0.017483,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":68.64,"sharesOutstanding":2675000,"nav":68.56,"aum":236522874.13,"bidAskSpread":0.002211,"preHourTrading":{"tag":"盘前","latestPrice":69.5,"preClose":68.64,"latestTime":"09:29 EDT","volume":3,"amount":208.5,"timestamp":1787664559664,"change":0.86,"changeRate":0.012529,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":70.33,"preClose":70.33,"latestTime":"19:30 EDT","volume":91,"amount":6415.95,"timestamp":1787700600971,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.770323,"impliedVol":0.2962,"impliedVolPercentile":0.9442},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","floatShares":3425000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.770323,"shares":3425000,"dividePrice":0,"high":70.59,"amplitude":0.017483,"preClose":68.64,"low":69.39,"week52Low":34.4999,"pbRate":"--","week52High":70.85,"institutionHeld":0,"latestPrice":70.33,"eps":0,"divideRate":0,"volume":86817,"delay":0,"ttmEps":0,"open":69.39,"prevYearClose":51.22,"prevWeekClose":69.11,"prevMonthClose":63.362,"prevQuarterClose":64.65,"fiveDayClose":69.09,"twentyDayClose":63.52,"sixtyDayClose":54.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SBIO\",params:#limit:5,,,undefined,":[{"date":"2024-12-19","symbol":"SBIO","amount":1.17346,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-19","defaultRemindTime":1734618600000,"name":"ALPS Medical Breakthroughs ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-19","currency":"USD","dateTimestamp":1734584400000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"SBIO","amount":0.07106,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"},{"market":"US","date":"2019-12-19","symbol":"SBIO","amount":0.01585,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2019-12-27","payableDate":"2019-12-20","currency":"USD","type":"dividend","dateTimestamp":1576731600000},{"market":"US","date":"2018-12-20","symbol":"SBIO","amount":0.78406,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2018-12-27","payableDate":"2018-12-21","currency":"USD","type":"dividend","dateTimestamp":1545282000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SBIO\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.78406,"currency":"USD"},{"executeDate":"2019-12-19","recordDate":"2019-12-20","paymentDate":"2019-12-27","value":0.01585,"currency":"USD"},{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.07106,"currency":"USD"},{"executeDate":"2024-12-19","recordDate":"2024-12-19","paymentDate":"2024-12-26","value":1.17346,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SBIO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SBIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660476707","title":"Sabio Boosts Margins and Programmatic Growth Ahead of Election-Driven Second Half","url":"https://stock-news.laohu8.com/highlight/detail?id=2660476707","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660476707?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:32","pubTimestamp":1787178771,"startTime":"0","endTime":"0","summary":"Sabio Holdings ( ($TSE:SBIO) ) has issued an update. Sabio reported consolidated gross revenues of $9.7 million in the second quarter of 2026, with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sabio-boosts-margins-and-programmatic-growth-ahead-of-election-driven-second-half?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sabio-boosts-margins-and-programmatic-growth-ahead-of-election-driven-second-half?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660520417","title":"Should Xenon’s Wider Q2 Losses to Fund Neurology Pipeline Require Action From Xenon (XENE) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660520417","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660520417?lang=en_us&edition=fundamental","pubTime":"2026-08-19 12:51","pubTimestamp":1787115071,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals Inc. recently reported second-quarter 2026 results, with net loss rising to US$110.74 million and basic loss per share from continuing operations at US$1.11, alongside a six‑month net loss of US$213.04 million and basic loss per share of US$2.28.\nThe widening losses compared with the same periods in 2025 give investors fresh insight into how Xenon is funding its ion-channel neurology pipeline ahead of key clinical and commercial milestones.\nWe will now examine how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xene/xenon-pharmaceuticals/news/should-xenons-wider-q2-losses-to-fund-neurology-pipeline-req","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xene/xenon-pharmaceuticals/news/should-xenons-wider-q2-losses-to-fund-neurology-pipeline-req","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","XENE","BK4139","SBIO","IBRN","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660411328","title":"Sabio Secures US$1.5 Million High-Interest Term Loan to Support Working Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2660411328","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660411328?lang=en_us&edition=fundamental","pubTime":"2026-08-19 11:02","pubTimestamp":1787108540,"startTime":"0","endTime":"0","summary":"Sabio Holdings ( ($TSE:SBIO) ) has shared an announcement. Sabio Holdings has secured a US$1.5 million non-revolving term loan facility through its...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sabio-secures-us1-5-million-high-interest-term-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sabio-secures-us1-5-million-high-interest-term-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492377","title":"AbbVie Closes USD 10B Multi-Tranche Senior Notes Offering to Fund Apogee Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492377?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:31","pubTimestamp":1787085094,"startTime":"0","endTime":"0","summary":"AbbVie closes USD 10B multi-tranche senior notes offering to fund Apogee dealAbbVie completed a USD 10 billion senior notes offering, including senior floating rate notes due 2028.Deal included fixed-rate senior notes across eight maturities from 2028 to 2066, with coupons from 4.5% to 6.1%.Proceeds earmarked to fund part of the cash consideration for AbbVie’s planned acquisition of Apogee Therapeutics.If the Apogee deal is terminated, AbbVie must redeem the floating-rate notes and fixed-rate notes due 2028-2038 at 101%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbzVC04:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1718418525.SGD","LU0256863811.USD","FTXH","GLAM","IE00BSNM7G36.USD","LU0708994859.HKD","IE00B19Z3581.USD","JDOC","LU0128525929.USD","LU0395794307.EUR","LU2237443622.USD","LU0114720955.EUR","LU0472753341.HKD","LU0417517546.SGD","SG9999001440.SGD","FHLC","LU0965508806.USD","LU0965509283.SGD","LU1989771016.USD","SBIO","IYH","IE000BZT7R73.USD","AGNG","VHT","LU2237443549.SGD","IE000SO60NU8.SGD","LU0203347892.USD","LU0310799852.SGD","PPH","LU1093756325.SGD","LU2125909593.SGD","BK4534","PJP","APGE","LU1839511570.USD","RXL","ABBV","LU0211328371.USD","LU0553294199.USD","LU2129689605.HKD","MEDX","IE00B4R5TH58.HKD","IXJ","TRUH","LU2433249047.HKD","LU0795875086.SGD","XLV","BK4533","LU0545039389.USD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492308","title":"CG Oncology Director Leonard Post Disposes of USD 74,540 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492308","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492308?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:31","pubTimestamp":1787085070,"startTime":"0","endTime":"0","summary":"CG Oncology director Leonard Post disposes of USD 74,540 in common sharesCG Oncology director Leonard E. Post sold 1,000 common shares at USD 74.54 on Aug. 14, 2026.The sale followed the exercise of 1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL77wBqM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CG Oncology Director Leonard Post Disposes of USD 74,540 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","SBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108000527","title":"China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks","url":"https://stock-news.laohu8.com/highlight/detail?id=1108000527","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108000527?lang=en_us&edition=fundamental","pubTime":"2026-08-14 15:38","pubTimestamp":1786693102,"startTime":"0","endTime":"0","summary":"China Galaxy Securities has released a research report stating that laboratory animals are a fundamental necessity for innovative drug research and development, with deep industry barriers. Two key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSKH","161027","BK1564","BK4585","BK0276","BIOY","601881","BK0188","SBIO","BBP","BK1147","APXH","BK4588","06881","PBE","LFSC","XLVI","GDOC","WRND","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160360","title":"Xenon Pharmaceuticals Director Steven Gannon Disposes of 10,000 Common Shares for $640,550","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160360","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160360?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:42","pubTimestamp":1786653738,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals director Steven Gannon disposes of 10,000 common shares for $640,550Xenon Pharmaceuticals director Steven Gannon sold 10,000 common shares on Aug. 11, 2026 at a weighted-average ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1zKHrZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Xenon Pharmaceuticals Director Steven Gannon Disposes of 10,000 Common Shares for $640,550","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRN","XENE","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166348","title":"Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166348?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:00","pubTimestamp":1786636814,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE) and Biogen (BIIB). Apog...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z9Z06.USD","PBE","APGE","BK4585","LU0889565916.HKD","IE00B894F039.SGD","BK4581","LU0128526141.USD","LU0320765992.SGD","BK4532","SBIO","LABU","BK4139","BK4588","BK4533","BK4137","LU0109394709.USD","LU0234570918.USD","XBI","LU0053671581.USD","BMED","LU0029874061.USD","HCSG","IE00B19Z9P08.USD","XLV","BIIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659187819","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659187819","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659187819?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:30","pubTimestamp":1786588220,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH). CG Onc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cg-oncology-inc-cgon-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cg-oncology-inc-cgon-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0130102774.USD","IE00B7SZLL34.SGD","LU1267930573.SGD","IE00B19Z3B42.SGD","BK4139","LU1201861249.SGD","LU0128526141.USD","BK4581","BK4566","HCSG","LU1267930813.SGD","XBI","LU0648001328.SGD","LU0708994859.HKD","BK4588","LU0980610538.SGD","LABU","LU0006061336.USD","LU0477156953.USD","SBIO","CGON","BK4135","LU0211328371.USD","LU0310799852.SGD","BK4082","LU0128525929.USD","LU0211327993.USD","BK4137","LU1267930490.SGD","CG","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0029864427.USD","LU0792757196.USD","XLV","LU0310800379.SGD","IE00B64PRP62.GBP","LU0130517989.USD","IE0002270589.USD","LU0889566641.SGD","ZBH","LU0029874061.USD","BK4504","GPZ","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142463773","title":"Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=1142463773","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142463773?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:10","pubTimestamp":1786543834,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) issued a statement on August 12, revealing that its stock price has experienced an unusual surge, with cumulative closing price gains exceeding...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0102","SBIO","BK4585","XLVI","WRND","600721","LFSC","APXH","IBB","BBP","BIOY","BK0216","BK4588","GDOC","GSKH","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658979608","title":"Apogee Therapeutics, Inc. : Btig Cuts to Neutral from Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658979608","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658979608?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:43","pubTimestamp":1786531419,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SBIO","LU0053671581.USD","APGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948566","title":"Apogee Therapeutics Gelar Rapat Khusus Pemegang Saham Lewat Webcast Langsung","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948566","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948566?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:03","pubTimestamp":1786478583,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics gelar rapat khusus pemegang saham lewat webcast langsungApogee Therapeutics menggelar rapat khusus pemegang saham pada 11 Agustus 2026 untuk membahas transaksi merger yang diusulka","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDLRjqrs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","FTXH","IE00B3PB1722.GBP","LU0114720955.EUR","LU0256863811.USD","IE000MB6IJN5.SGD","LU0689472784.USD","PPH","BK4581","LU0417517546.SGD","LU1244550221.USD","IE000SO60NU8.SGD","LU1003077747.HKD","GLAM","RXL","SG9999003800.SGD","IE00B2B36J28.USD","LU0310800379.SGD","IYH","LU0124676726.USD","XLV","LU0289961442.SGD","FHLC","LU0949170772.SGD","JDOC","LU1496350502.SGD","ABBV","MEDX","LU1670627923.USD","LU0256863902.USD","LU2129689605.HKD","IXJ","SBIO","IE000F7OJYX1.SGD","IE0009355771.USD","LU0158827948.USD","LU0053671581.USD","LU0395794307.EUR","TRUH","LU2347655073.USD","IE00BGHQF631.EUR","AGNG","LU1162221912.USD","PJP","IE00B42XCP33.USD","LU0234572021.USD","VHT","APGE","IE00BSNM7G36.USD","IE00BVYPNW00.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658433917","title":"Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658433917","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658433917?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:10","pubTimestamp":1786471809,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-relmada-therapeutics-rlmd-surgery-partners-sgry-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-relmada-therapeutics-rlmd-surgery-partners-sgry-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE","LU0128526141.USD","BK4588","HCSG","BK4139","SBIO","XLV","BK4581","PSIL","BK4585","LU0053671581.USD","SGRY","LU0029874061.USD","LABU","XBI","BK4137","BK4007","RLMD","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174341976","title":"Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1174341976","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174341976?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:08","pubTimestamp":1786450094,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) has issued a stock trading risk warning announcement, stating that it is a CRO enterprise primarily focused on the research and development of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOY","SBIO","GDOC","APXH","XLVI","LFSC","BK0216","BK4588","600721","GSKH","WRND","BK4585","PBE","IBB","BK0102","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658343990","title":"J.P. Morgan Remains a Buy on Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658343990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658343990?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:56","pubTimestamp":1786449382,"startTime":"0","endTime":"0","summary":"In a report released today, Tessa Romero from J.P. Morgan maintained a Buy rating on Xenon, with a price target of $82.00. Romero covers the Health...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0912757837.SGD","LU0390134368.USD","LU1720051108.HKD","LU0106831901.USD","LU1732799900.SGD","LU1720051017.SGD","LU2357305700.SGD","LU0795875086.SGD","KBWB","LU2089283258.USD","LU0234570918.USD","BK4534","LU1244550494.USD","BK4139","LU1548497426.USD","LU2264538146.SGD","IE00B775SV38.USD","LU0971096721.USD","IBRN","XENE","BK4588","LU0053666078.USD","LU0882574139.USD","LU1363072403.SGD","LU1668664300.SGD","LU1791710582.SGD","LU2271345857.HKD","SBIO","LU0158827781.USD","LU2089284900.SGD","LU0106261372.USD","LU1064131342.USD","LU0098860793.USD","LU2028103732.USD","IE00B3S45H60.SGD","LU0320765646.SGD","LU1732800096.USD","LU2133065610.SGD","LU1989772923.USD","LU1244550577.SGD","LU2023251221.USD","LU1244550221.USD","BK4516","LU0314104364.USD","LU1074936037.SGD","LU1791710400.SGD","LU0225283273.USD","LU0210528500.USD","LU0795875169.SGD","IAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118729610","title":"AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=1118729610","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118729610?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:12","pubTimestamp":1786428745,"startTime":"0","endTime":"0","summary":"A research report from Orient Securities Company Limited highlights that as global regulatory shifts accelerate, the large-scale application of AI in pharmaceuticals is rapidly advancing. It has...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0276","LFSC","BIOY","WRND","AIPO","VTHR","BK1147","BK0188","PBE","AGIX","XLVI","CHAT","QTOC","03958","BK0183","BK1564","BK0028","600958","BK0012","SBIO","BBP","BK4585","BK4588","APXH","GSKH","IBB","GDOC","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658625839","title":"Apogee Therapeutics’ Merger Faces Significant Execution Risks, Potential $381 Million Termination Fee and Stock Price Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2658625839","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658625839?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:00","pubTimestamp":1786428020,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics, Inc. (APGE) has disclosed a new risk, in the Corporate Activity and Growth category. Apogee Therapeutics, Inc. faces execution...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apogee-therapeutics-merger-faces-significant-execution-risks-potential-381-million-termination-fee-and-stock-price-pressure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apogee-therapeutics-merger-faces-significant-execution-risks-potential-381-million-termination-fee-and-stock-price-pressure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","APGE","LU0053671581.USD","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938940","title":"Apogee Net Loss Widens to $85.85 Million in Q2 FY26; R&D Expenses Rise to $67.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938940","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938940?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:06","pubTimestamp":1786359994,"startTime":"0","endTime":"0","summary":"Apogee net loss widens to $85.85 million in Q2 FY26; R&D expenses rise to $67.3 millionApogee Therapeutics posted a Q2 2026 net loss of $85.85 million, widening from $66.1 million a year earlier.R&D e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLsYr5J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","IE00BLSP4452.SGD","LU2237443465.HKD","IE00BVYPNV92.GBP","IXJ","LU0211328371.USD","TRUH","BCDF","FHLC","BK4533","IE00BJJMRZ35.SGD","JDOC","LU0942090050.USD","LU0069063385.USD","SBIO","LU0985320562.USD","PPH","XLV","LU0289739699.SGD","LU1291159041.SGD","LU2125909247.SGD","LU2095319765.USD","GLAM","LU2089283258.USD","IE000MB6IJN5.SGD","LU2468319806.SGD","NDAQ","IE0002270589.USD","ABBV","LU0912757837.SGD","IE00BJT1NW94.SGD","BK4581","IE00BLSP4239.USD","LU0965508806.USD","LU1732800096.USD","MEDX","RXL","LU1037948897.HKD","IE00B3PB1722.GBP","BK4559","IE0009355771.USD","VHT","APGE","PJP","LU2023251221.USD","LU2433249047.HKD","AGNG","IYH","SG9999014013.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980067","title":"Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980067?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA10RXHS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APGE","BK4139","LU0053671581.USD","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658893387","title":"Apogee Therapeutics, - Q2 2026 Net Loss $85.90 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658893387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658893387?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA10RXHS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","APGE","SBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":70,"code":"91000000","status":"200"}]}}